Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
| Citation | Khunti, Kamlesh, et al. “Draft FDA Guidance for Assessing the Safety of Glucose Lowering Therapies: A Missed Opportunity?”. 2020. The Lancet. Diabetes & Endocrinology, vol. 8, no. 10, 2020, pp. 810–811. |
| Center | North Carolina |
| Author | Kamlesh Khunti, Melanie J Davies, Nikolaus Marx, John B Buse |
| Year of Publication |
2020
|
| Journal |
The lancet. Diabetes & endocrinology
|
| Volume |
8
|
| Issue |
10
|
| Number of Pages |
810-811
|
| Date Published |
12/2020
|
| ISSN Number |
2213-8595
|
| DOI |
10.1016/S2213-8587(20)30302-8
|
| Alternate Journal |
Lancet Diabetes Endocrinol
|
| PMID |
32946819
|
| Download citation |